ES2134184T3 - Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica. - Google Patents

Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.

Info

Publication number
ES2134184T3
ES2134184T3 ES88118781T ES88118781T ES2134184T3 ES 2134184 T3 ES2134184 T3 ES 2134184T3 ES 88118781 T ES88118781 T ES 88118781T ES 88118781 T ES88118781 T ES 88118781T ES 2134184 T3 ES2134184 T3 ES 2134184T3
Authority
ES
Spain
Prior art keywords
acne
etisterone
androgenetic alopecia
topical treatment
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88118781T
Other languages
English (en)
Inventor
Christoph Prof Dr Luderschmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2134184(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2134184T3 publication Critical patent/ES2134184T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UTILIZACION DE ETISTERONA, NOR - ETISTERONA O SU ESTER DEL ACIDO 17 - CARBOXILICO PARA EL TRATAMIENTO DEL ACNE O DE LA ALOPECIA ANDROGENETICA.
ES88118781T 1987-11-13 1988-11-11 Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica. Expired - Lifetime ES2134184T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873738620 DE3738620A1 (de) 1987-11-13 1987-11-13 Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie

Publications (1)

Publication Number Publication Date
ES2134184T3 true ES2134184T3 (es) 1999-10-01

Family

ID=6340460

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88118781T Expired - Lifetime ES2134184T3 (es) 1987-11-13 1988-11-11 Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.

Country Status (6)

Country Link
US (1) US5094857A (es)
EP (1) EP0316780B1 (es)
JP (1) JP2788739B2 (es)
AT (1) ATE179594T1 (es)
DE (2) DE3738620A1 (es)
ES (1) ES2134184T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
DE3936328A1 (de) * 1989-10-27 1991-05-02 Schering Ag Pharmazeutische praeparate
US5756094A (en) * 1991-03-27 1998-05-26 Trustees Of The University Of Pennsylvania Methods for stimulating follicular growth
EP0821592A4 (en) * 1995-04-20 2000-03-01 Univ Pennsylvania COMPOSITIONS AND METHODS FOR REGULATING HAIR GROWTH
US6241998B1 (en) 1999-02-02 2001-06-05 Acutek International Dermatological patch
GB2421183A (en) * 2004-12-17 2006-06-21 Stegram Pharmaceuticals Ltd Topical formulations for use in the treatment or prevention of skin cancers
JP5544458B2 (ja) * 2005-07-12 2014-07-09 アンピオ ファーマシューティカルズ，インコーポレイテッド 疾病を治療するための医薬製品の製造においてトリロスタンｉｉｉを使用する方法及びトリロスタンｉｉｉを含む医薬製品
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
JP5833549B2 (ja) 2009-06-22 2015-12-16 アンピオ ファーマシューティカルズ，インコーポレイテッド 血管透過性亢進を抑制するためのダナゾールを含む製薬組成物
SG177302A1 (en) * 2009-06-22 2012-02-28 Dmi Acquisition Corp Methods and products for treatment of diseases
CN104968350A (zh) 2012-12-19 2015-10-07 安皮奥制药股份有限公司 疾病的治疗方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL190146A (es) * 1953-08-26
US2964537A (en) * 1956-06-16 1960-12-13 Schering Ag Therapeutically valuable carboxylic acid esters of 17-alkyl-19-nor-testosterone
US4078061A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of treating acne
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US5008257A (en) * 1982-05-18 1991-04-16 University Of Florida Brain-specific drug delivery
US4829070A (en) * 1982-05-18 1989-05-09 University Of Florida Novel redox carriers for brain-specific drug delivery
US4900837A (en) * 1982-05-18 1990-02-13 University Of Florida Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors
US4880921A (en) * 1982-05-18 1989-11-14 University Of Florida Brain-specific drug delivery
US4540564A (en) * 1982-05-18 1985-09-10 University Of Florida Brain-specific drug delivery
US4824850A (en) * 1982-05-18 1989-04-25 University Of Florida Brain-specific drug delivery
BE898057A (fr) * 1982-10-21 1984-02-15 Mortimer Christopher H Traitement de la calvitie androide.
GB2131292B (en) * 1982-12-01 1987-03-11 Dr Christopher H Mortimer Progestational pharmaceutical formulations
AU565915B2 (en) * 1982-12-31 1987-10-01 Mortimer, C.H. Pharmaceutical composition of antibiotic and anti- androgen
GB8413070D0 (en) * 1984-05-22 1984-06-27 Mortimer C H Treatment of hair loss
GB8413069D0 (en) * 1984-05-22 1984-06-27 Mortimer C H Treatment of hair loss
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
CH674618A5 (es) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE3888269T2 (de) * 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US4994278A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Breathable backing
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
DE3836862A1 (de) * 1988-10-27 1990-05-03 Schering Ag Mittel zur transdermalen applikation von steroidhormonen

Also Published As

Publication number Publication date
US5094857A (en) 1992-03-10
EP0316780B1 (de) 1999-05-06
ATE179594T1 (de) 1999-05-15
DE3738620A1 (de) 1989-05-24
JPH01301623A (ja) 1989-12-05
DE3856329D1 (de) 1999-06-10
JP2788739B2 (ja) 1998-08-20
EP0316780A1 (de) 1989-05-24

Similar Documents

Publication Publication Date Title
DE50010931D1 (de) Substituierte benzimidazole
ES2000036A4 (es) Producto cosmetico a base de n-hidroxipropilquitosanas, nuevas n-hidroxipropilquitosanas, asi como procedimiento para su fabricacion.
DK0892638T3 (da) Liposombaseret, topisk vitamin D-præparat
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
IT1237472B (it) Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
ES540645A0 (es) Aparato para el tratamiento del plasma.
ES2042742T3 (es) Procedimiento para preparar furanonas antiinflamatorias.
ES2134184T3 (es) Empleo de etisterona para el tratamiento topico del acne o de la alopecia androgenetica.
PA8467301A1 (es) Nuevos derivados del acido dihidroxihexanoico
IT1164821B (it) Benzammidi eterocicliche sostituite procedimento per la loro produzione e loro impiego come modificatori di comportamento
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
MX9205435A (es) Derivados del acido imidazolil-propenico substituidos y procedimiento para su fabricacion.
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
MX9205434A (es) Derivados del acido imidazolil-propenico substituidos ciclicamente y procedimiento para su fabricacion.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
ES2056983T3 (es) Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
YU13499A (sh) Primena 1-hidroksi-2-piridona za lečenje seboroitičnog dermatitisa
ES2065980T3 (es) Uso del acido 5-aminosalicilico en el tratamiento de alteraciones dermatologicas.
ES540213A0 (es) Procedimiento para la obtencion de esteres del acido salici-lico, de efecto perfumante
ES2014438B3 (es) Derivados del acido 2-fosfonobutano-1,2,4tricarboxilico, como agentes emulsivos.
ES537480A0 (es) Procedimiento para la fabricacion de la reductasa del acido 2, 5-diceto-d-gluconico
MX9302419A (es) Derivados de acido tetronico, tiotetronico y tetramico.
BR0013751A (pt) Processo para produção de derivados de ácido naftiridina-3-carboxìlico
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 316780

Country of ref document: ES